Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Home Newsfeeds Starbucks Shares Down 3%; Co To Host Investor Day 2022 Today

Events
News

Starbucks Shares Down 3%; Co To Host Investor Day 2022 Today

https://event.on24.com/wcc/r/3897312/F58C6DC171BC69DB68DC57028CA5AEEC

byBenzinga Newsdesk

September 13, 2022

1 minute read

https://event.on24.com/wcc/r/3897312/F58C6DC171BC69DB68DC57028CA5AEEC

Mizuho Maintains Buy on Pentair, Raises Price Target to $65

By Benzinga Newsdesk

February 1, 8:38 AM

Mizuho analyst Brett Linzey maintains Pentair (NYSE:PNR) with a Buy and raises the price target from $60 to $65.

PNR

Why Arhaus Shares Are Nosediving

By Henry Khederian

August 16, 1:20 PM

Arhaus Inc (NASDAQ: ARHS) Arhaus shares are trading lower by 13.6% to $10.54 Wednesday afternoon after the company announced an underwritten public offering of 12 million shares of

ARHS

In Vivo Efficacy Of Matinas BioPharma’s Oral MAT2203 In Pulmonary Mucormycosis Published In Journal Of Antimicrobial Agents And Chemotherapy

By Benzinga Newsdesk

April 30, 8:16 AM

Matinas BioPharma Holdings, Inc. (NYSE:MTNB), a clinical-stage biopharmaceutical company focused on delivering groundbreaking therapies using its lipid nanocrystal (LNC) platform delivery technology, announces that

MTNB

Why Is Hyatt Hotels Stock Sliding Today?

By Shivani Kumaresan

May 9, 10:54 AM

Hyatt Hotels reports Q1 sales growth of 2%, surpassing analyst estimates. Comparable RevPAR rises by 5.5%, reflecting strong performance. Adjusted EBITDA dips by 5.9% to $252 million, while adjusted EPS falls short at $0.71.

Starbucks Shares Down 3%; Co To Host Investor Day 2022 Today

Related Posts

Mizuho Maintains Buy on Pentair, Raises Price Target to $65

Why Arhaus Shares Are Nosediving

In Vivo Efficacy Of Matinas BioPharma’s Oral MAT2203 In Pulmonary Mucormycosis Published In Journal Of Antimicrobial Agents And Chemotherapy

Why Is Hyatt Hotels Stock Sliding Today?